New surveillance data published this week by the Centers for Disease Control and Prevention (CDC) show a slight decline in US tuberculosis (TB) cases in 2025.
The provisional report of data submitted to the CDC’s National Tuberculosis Surveillance System shows 10,260 TB cases were reported in 2025, with a corresponding rate of 3.0 cases per 100,000 population. That represents a 1% decline in cases and 2% decline in the national TB rate from 2024 to 2025.
Twenty-six states and the District of Columbia reported decreases in cases. Among the states that reported a substantial decline in cases was Kansas, which saw an outbreak of TB in the Kansas City metro area in 2024 that was among the largest in the United States since the CDC began tracking the disease.
As with previous years, the vast majority (77%) of US TB cases were in non-US–born people, with a corresponding rate of 15.4 cases per 100,000. The rate for US-born people was 0.8 per 100,000. One-third of all cases involved people aged 25 to 44. Compared with 2024, TB cases declined among all age-groups except those 65 and older.
Pandemic-related increase in TB cases
The decline follows a steady rise in US TB cases from 2021 through 2024, an increase the CDC has said may be related to disruptions to TB services caused by the COVID-19 pandemic. Those disruptions, primarily in 2020, could have resulted in delayed diagnoses that were reported in subsequent years. Prior to the pandemic, US incidence of the disease, which sickens more than 10 million people a year globally and kills more than 1 million, had been steadily declining.
The United States has one of the lowest TB rates in the world, and most US residents have a low risk of infection. But the CDC estimates that up to 13 million people in the country have latent TB, which means they’re infected but don’t feel sick and can’t transmit the disease. The agency says finding and treating people with latent TB is essential for treating and controlling the disease.